Revolution Medicines, Inc. is 4.2x more valuable than REPLIGEN CORP by market capitalization ($30.65 B vs $7.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RGEN | RVMD |
|---|---|---|
| Market cap | $7.38 B | $30.65 B |
| US-listed rank | #1115 | #454 |
| Revenue (latest FY) | $141.24M | $0.00 |
| Net income (latest FY) | $48.89M | -$1.13B |
| Net margin | 34.6% | - |
| P/E (trailing FY) | 150.9 | - |
| SEC filings | 1,331 | 782 |
Revolution Medicines, Inc. is 4.2x more valuable than REPLIGEN CORP by market capitalization ($30.65 B vs $7.38 B).
In their latest fiscal years, REPLIGEN CORP reported $141.24M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: REPLIGEN CORP and Revolution Medicines, Inc., or browse the full rankings.